3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Carcinoma, Non-Small-Cell Lung
163
Lung Neoplasms
53
Neoplasms
14
Neoplasm Metastasis
10
NSCLC
10
Brain Neoplasms
10
Carcinoma
9
Meningeal Carcinomatosis
6
Colorectal Neoplasms
5
Bronchial Neoplasms
5
Thoracic Neoplasms
4
Respiratory Tract Neoplasms
3
Respiratory Tract Diseases
3
Pancreatic Neoplasms
3
Ovarian Neoplasms
3
Neoplasms by Site
3
Lung Diseases
3
Carcinoma, Squamous Cell
3
Breast Neoplasms
3
Adenocarcinoma of Lung
3
Adenocarcinoma
3
Uterine Neoplasms
2
Uterine Cervical Neoplasms
2
Urinary Bladder Neoplasms
2
Stomach Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Solid Tumor
2
Prostatic Neoplasms
2
Noonan Syndrome
2
Non Small Cell Lung Cancer Metastatic
2
Interventions
Etoposide
154
Carboplatin
142
Cisplatin
104
Topotecan
74
durvalumab
48
atezolizumab
46
Irinotecan
44
pembrolizumab
39
Paclitaxel
34
Nivolumab
33
Radiotherapy
29
anlotinib
23
PM 01183
22
Gemcitabine
21
Drug Therapy
20
apatinib
19
Ipilimumab
18
Docetaxel
17
Temozolomide
16
Platinum
16
Radiosurgery
15
Pemetrexed
14
toripalimab
13
tislelizumab
13
olaparib
13
Bevacizumab
13
amrubicin
11
Magnetic Resonance Spectroscopy
11
Cyclophosphamide
11
rovalpituzumab tesirine
10
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Small Cell Lung Carcinoma
×
osimertinib
×
Clear all
NCT07153055
2025-12-18
LOTS
Indiana University
Phase 1/2
Not yet recruiting
16 enrolled